Abstract
The current (eighth) staging system should be used for staging of small cell lung cancer despite the fact that patients with small cell lung carcinoma (SCLC) were staged as “limited” and “extensive” [1]. Although a very small subset of patients with SCLC survived longer than 5 years compared with 15–25% of non-SCLC patients, the discrepancy can be explained by the biologic behavior of SCLC, which results in dissemination to regional lymph nodes and/or distant metastatic sites in more than 90% of patients at initial presentation, thereby precluding surgery. Even patients with apparently “limited stage” or “operable” tumors probably have micrometastatic deposits at distant sites, which have the potential to proliferate if only local therapeutic modalities, such as surgery or radiotherapy, are used.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.
Shepherd FA, Crowley J, Van Houtte P, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol. 2007;2:1067–77.
Valieres E, Shephard FA, Crowley J, et al. The IASLC proposals regarding the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor node, metastasis classification for lung cancer. J Thorac Oncol. 2009;4:1049–59.
Yu JB, Decker RH, Detterbeck F, et al. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol. 2010;5:215–9.
Nicholson AG, Chansky K, Crowley J, et al. The international association for the study of lung cancer staging project: proposals for the revision of the clinical and pathological staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(3):300–11.
Badzio A, Kurowski K, Karnicka-Mlodkowska H, et al. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer. Eur J Cardiothorac Surg. 2004;26:183–8.
Lucchi M, Mussi A, Chella A, et al. Surgery in the management of small cell lung cancer. Eur J Cardiothorac Surg. 1997;12:689–93.
Shepherd FA, Ginsberg RJ, Feld R. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience. J Thorac Cardiovasc Surg. 1991;101:385–93.
Shields TW, Higgins GA Jr, Matthews MJ, et al. Surgical resection in the management of small cell carcinoma of the lung. J Thorac Cardiovasc Surg. 1982;84:481–8.
Eberhardt W, Stamatis G, Stuschke M, et al. Prognostically oriented multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial. Br J Cancer. 1999;81:1206–12.
Suzuki R, Tsuchiya R, Ichinose Y. Phase II trial of postoperative adjuvant cisplatin/etoposide (PE) in patients with completely resected stage I-IIIA small cell lung cancer (SCLC) (abstract). Proc Am Soc Clin Oncol. 2000;19(492a).:abstract 1925
Lad T, Piantadosi S, Thomas P, et al. A prospective randomized trial to determine the benefit of surgical resection of residual disease following the response of small cell lung cancer to combination chemotherapy. Chest. 1994;106:320S–3S.
Prager RL, Foster JM, Hainsworth JD, et al. The feasibility of adjuvant surgery in limited-stage small cell carcinoma: a prospective evaluation. Ann Thorac Surg. 1984;38(6):622–6.
Williams CJ, McMillan I, Lea R, et al. Surgery after initial chemotherapy for localizede small-cell carcinoma of the lung. J Clin Oncol. 1987;5(10):1579–88.
Baker RR, Ettinger DS, Ruckdeschel JD, et al. The role of surgery in the management of selected patients with small cell carcinoma of the lung. J Clin Oncol. 1987;5(5):697–702.
Shepherd FA, Evans WK, Feld R, et al. Adjuvant chemotherapy following surgical resection for small cell carcinoma of the lung. J Clin Oncol. 1988;6(5):832–8.
Liu T, Chen Z, Dang J, et al. The role of surgery in stage I to III small cell lung cancer: a systematic review and meta-analysis. PLoS One. 2018;13(12):e0210001.
Xu L, Zhang G, Song S, et al. Surgery for small cell lung cancer. Medicine. 2019;98(40):e17214.
Yang C-FJ, Chan DY, Shah SA, et al. Long-term survival after surgery compared with concurrent Chemoradiation for node-negative small cell lung cancer. Ann Surg. 2018;268(6):1105–12.
Jin K, Zhang K, Zhou F, et al. Selection of candidates for surgery as local therapy among early-stage small cell lung cancer patients: a population-based analysis. CancerCommun. 2018;38(1):5.
Dou X, Wang Z, Wang L, et al. Analysis of efficacy of surgical treatment for IIIa small cell lung cancer. Zhongguo Fei Ai Za Zhi. 2017;20(2):88–92.
Nakanishi K, Mizuno T, Sakakura N, et al. Salvage surgery for small cell lung cancer after chemoradiotherapy. Jpn J Clin Oncol. 2019;49(4):389–92.
Li Y, Hu S, Xie J, et al. Effects of surgery on survival of elderly patients with stage I small-cell lung cancer: analysis of the SEER database. J Cancer Res Clin Oncol. 2019;145(9):2397–404.
Hamilton G, Rath B, Ulsperger E. A review of the role of surgery for small cell lung cancer and the potential prognostic value of enumeration of circulating tumor cells. Eur J Surg Oncol. 2016;42(9):1296–302.
Weckler BC, Baldes N, Schirren J. Survival following multimodality treatment including surgery for stage IA-IIIB small-cell lung cancer. Thorac Cardiovasc Surg. 2019;67(4):291–8.
Barnes H, See K, Barnett S, et al. Surgery for limited-stage small cell lung cancer. Cochrane Database Syst Rev. 2017;21(4):CD011917.
Kalemkerian GP, Loo BW, Akerley W, et al. NCCN guidelines insights: small cell lung cancer. J Natl ComprCancNetw. 2018;16 https://doi.org/10.6004/jnccn.2018.0079.
Schneider BJ, Ismaila N, Aerts J, et al. Lung cancer surveillance after definitive curative-intent therapy: ASCO guideline. J Clin Oncol. 2019;38:753–69.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Turna, A., Özçıbık, G. (2023). Surgery for Small Cell Lung Cancer. In: Cingi, C., Yorgancıoğlu, A., Bayar Muluk, N., Cruz, A.A. (eds) Airway Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-22483-6_72-1
Download citation
DOI: https://doi.org/10.1007/978-3-031-22483-6_72-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-22482-9
Online ISBN: 978-3-031-22483-6
eBook Packages: MedicineReference Module Medicine